Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode of Purchase (Prescription Drugs, Over The Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode of Purchase (Prescription Drugs, Over The Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 $3500.00 | Pages : 357 | Published : January 2022 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Gastrointestinal Drugs Market Definition

The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities (organizations, sole traders and partnerships) that are engaged in manufacturing gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome.

Gastrointestinal conditions are disorders of the digestive system, involving the gastrointestinal tract, namely the oesophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. The key gastrointestinal diseases drug categories include antiulcerants (anti-peptic agents, antacids, antagonists, proton pump inhibitors, sucralfate, and misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, and simulant/irritant. The gastrointestinal drugs industry develops drugs to cure, treat, or prevent disease that mainly affect the gastrointestinal tract. Gastrointestinal drugs similar to other pharma drugs are subject to various laws and regulations that deal with patenting, testing, safety, efficacy, and marketing.

Book your 30 minutes free consultation with our research experts

Contact Us

Gastrointestinal Drugs Market Size

The global gastrointestinal drugs market reached a value of nearly $46,679.8 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.9%since 2015. The gastrointestinal drugs market is expected to grow from $46,679.8 million in 2020 to $62,191.6 million in 2025 at a rate of 5.9%. The gastrointestinal drugs market is then expected to grow at a CAGR of 5.1% from 2025 and reach $79,871.1 million in 2030.

Growth in the historic period in the gastrointestinal drugs market resulted from changes in lifestyles, strong economic growth in emerging markets, increase in pharmaceutical R&D expenditure, increase in insurance coverage, aging population trends, and increased healthcare expenditure.The gastrointestinal drugs market was restrained by patent expiration of drugs, challenges due to regulatory changes, low healthcare access, and increased preference for biological treatments.

Going forward, increasing prevalence of gastrointestinal diseases, new methods for drug discovery, new methods for drug delivery and monitoring, rise in healthcare expenditure, and increasing geriatric population will drive the growth in the gastrointestinal drugs market. Factors that could hinder the growth of the gastrointestinal drugs market in the future include high costs of drugs, rising popularity of alternative therapies, and the coronavirus pandemic.

Gastrointestinal Drugs Market Drivers

The key drivers of the gastrointestinal drugs market include:

New Methods for Drug Delivery and Monitoring

The gastrointestinal drugs market is expected to be positively impacted by the new emerging drug delivery methods.  Innovative pharmaceutical approaches are being explored to improve regional drug targeting in the GI tract, with the majority still in the infancy stages of translational development. For example, the use of multi particulate dosage systems, such as nanoparticles, has shown promising results in improving gastrointestinal drug delivery compared to single-unit dose formulations. Effective translation will depend on rational dosage form design to enable improvements in gastrointestinal drug delivery for the treatment of both systemic diseases and local gastrointestinal diseases. Along with these advancements, ingestible biosensors that can reside in the body for long periods of time hold the promise of radically transforming drug delivery and clinical treatment and evaluation. Such devices could be used to sense conditions in hard to reach places, like the gastrointestinal tract. These new methods are expected to drive the gastrointestinal drugs market in the forecast period.

Gastrointestinal Drugs Market Restraints

The key restraints on the gastrointestinal drugs market include:

High Costs Of Drugs

High costs associated with drugs is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public healthcare funding. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, and Serbia, pharmaceutical companies are faced with the pressure of reducing the price of drugs. For instance, according to a report by NorthWest Pharmacy, Linzess, a drug used to treat irritable bowel syndrome (IBS)-C costs around $474.00 for a 30-day supply of 145mcg pills in the United States. The high costs associated with drugs are putting pressure on the revenues of gastrointestinal drug manufacturers.

Gastrointestinal Drugs Market Trends

Major trends influencing the gastrointestinal drugs market include:

Floating Drug Delivery System

Gastrointestinal drugs manufacturers are using floating drug delivery systems for the treatment of local infections related to the gastrointestinal tract. The bilayer floating tablet is the core component of the floating drug delivery system (FDDS), which is used to extend the gastric residence time in the stomach. It's best for treating local infections including peptic ulcers, gastritis, Zollinger-Ellison syndrome, indigestion, and other gastrointestinal tract infections, but it can also be used for systemic infections. Drugs that are acid labile and have a short half-life benefited from FDDS protection. It also increases drug bioavailability, decreases drug waste, and extends drug residence duration. Various technologies are now being employed in the development of FDDS. The inclusion of novel drug delivery technologies into bilayer floating tablets has also expanded the usefulness of FDDS. Polymers play a key role in the creation of FDDS because they serve as drug carriers and determine gastric retention time and drug protection. FDDS is also a simple, inexpensive, and more convenient form of dual medication delivery.

Use of Biomarkers for Drug Development

Gastrointestinal drugs manufacturing companies are increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the gastrointestinal drugs market. Biomarkers are biological indicators which are objectively measured and evaluated for biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. They are helpful to predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in the gastrointestinal drugs market are investing in the development of biomarkers for use in various activities such as tracking drug activity, studying pharmacodynamics (relationship between the drug concentration at the site of action and the biochemical and physiological effect) of drugs and to study diseases and treatment pathways. For instance, in August 2021, Second Genome, a biotechnology company, has teamed up with Arena Pharmaceuticals to find gastrointestinal biomarkers. Second Genome will use Arena's Cultivate clinical trial in conjunction with their sg-4-sight research engine to identify microbiome biomarkers in order to "guide patient stratification and enhance potential treatments.

Opportunities And Recommendations In The Gastrointestinal Drugs Market

Opportunities –The top opportunities in the gastrointestinal drugs market segmented by type will arise in the antiulcerants segment, which will gain $7,123.0 million of global annual sales by 2025.The top opportunities in the gastrointestinal drugs market segmented by distribution channel will arise in the retail pharmacies segment, which will gain $14,178.1 million of global annual sales by 2025. The top opportunities in the gastrointestinal drugs market segmented by route of administration will arise in the parenteral segment, which will gain $7,941.0 million of global annual sales by 2025. The top opportunities in the gastrointestinal drugs market segmented by drug classification will arise in the branded segment, which will gain $8,974.5 million of global annual sales by 2025. The top opportunities in the gastrointestinal drugs market segmented by mode of purchase will arise in the prescription segment, which will gain $11,999.5 million of global annual sales by 2025.  The gastrointestinal drugs market size will gain the most in the USA at $5,756.2 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the gastrointestinal drugs companies to focus on using biomarkers for drug development, build partnerships and collaborations, expand in developed markets, set up authorized distributors and sales representatives, bundled payments, provide competitively priced offerings in low-income countries, participate in trade shows and events, increase visibility through business websites and listing websites, leverage social media, targeting the geriatric population and to spread awareness.

Gastrointestinal Drugs Market Segmentation

The gastrointestinal drugs market is segmentation by type, segmentation by distribution channel, segmentation by route of administration, segmentation by drug classification, segmentation by mode of purchase.
By Type -
The gastrointestinal drugs market is segmented by type into:
    • a) Antacids
    • b) Antiulcerants
    • c) Antiemetics and Antinauseants
    • d) Antidiarrheals
    • e) Others
The antiulcerants was the largest segment of the gastrointestinal drugs market segmented by type, accounting for 51.2% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the gastrointestinal drugs market segmented by type, at a CAGR of 6.9% during 2020-2025.
By Distribution Channel–
The gastrointestinal drugs market is segmented by distribution channel into:
    • a) Hospital Pharmacies
    • b) Retail Pharmacies/ Drug Stores
    • c) Others
The retail pharmacies/ drug stores were the largest segment of the gastrointestinal drugs market segmented by distribution channel, accounting for 52.5% of the total in 2020. Going forward, the retail pharmacies/ drug stores segment is expected to be the fastest growing segment in the gastrointestinal drugs market segmented by distribution channel, at a CAGR of 9.6% during 2020-2025.
By Root of Administration–
The gastrointestinal drugs market is segmented by root of administration into:
    • a) Oral
    • b) Parenteral
The parenteral was the largest segment of the gastrointestinal drugs market segmented by route of administration, accounting for 59.5% of the total in 2020. Going forward, the oral segment is expected to be the fastest growing segment in the gastrointestinal drugs market segmented by route of administration, at a CAGR of 7.0% during 2020-2025.
By Drug Classification –
The gastrointestinal drugs market is segmented by drug classification into:
    • a) Branded Drugs
    • b) Generic Drugs
The branded drugs was the largest segment of the gastrointestinal drugs market segmented by drug classification, accounting for 64.2% of the total in 2020. Going forward, the generic drugs segment is expected to be the fastest growing segment in the gastrointestinal drugs market segmented by drug classification, at a CAGR of 6.8% during 2020-2025.
By Mode of Purchase –
The gastrointestinal drugs market is segmented by mode of purchase into:
    • a) Prescription Drugs
    • b) Over The Counter Drugs
The prescription drugs was the largest segment of the gastrointestinal drugs market segmented by mode of purchase, accounting for 79.3% of the total in 2020. Going forward, the over-the-counter drugs segment is expected to be the fastest growing segment in the gastrointestinal drugs market segmented by mode of purchase, at a CAGR of 6.4% during 2020-2025.
By Geography - The gastrointestinal drugs market is segmented by geography into
      o Asia Pacific
      • • Australia
      • • China
      • • Hong Kong
      • • Japan
      • • India
      • • Indonesia
      • • Malaysia
      • • New Zealand
      • • Philippines
      • • Singapore
      • • South Korea
      • • Thailand
      • • Vietnam
    o North America
    • • Canada
    • • Mexico
    • • USA
    o South America
    • • Argentina
    • • Brazil
    • • Chile
    • • Colombia
    • • Peru
    • • Venezuela
    o Western Europe
    • • Austria
    • • Belgium
    • • Denmark
    • • Finland
    • • France
    • • Germany
    • • Ireland
    • • Italy
    • • Netherlands
    • • Norway
    • • Portugal
    • • Spain
    • • Sweden
    • • Switzerland
    • • UK
    o Eastern Europe
    • • Czech Republic
    • • Poland
    • • Romania
    • • Russia
    o Middle East
    • • Saudi Arabia
    • • Israel
    • • Turkey
    • • UAE
      • o Africa
      • • Egypt
      • • Nigeria
      • • South Africa
North America was the largest region in the gastrointestinal drugs market, accounting for 47.6% of the total in 2020. It was followed by the Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the gastrointestinal drugs market will be South America and Africa where growth will be at CAGRs of 9.6% and 8.3% respectively during 2020-2025. These will be followed by Middle East and Asia Pacific, where the markets are expected to register CAGRs of 7.7% and 6.7% respectively during 2020-2025.

Gastrointestinal Drugs Competitive Landscape

Major Competitors Are:

  • Sanofi
  • Bayer AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • The Procter & Gamble Company
  • PV Pharma Healthcare
  • Roche India
  • Arlak Biotech
  • Healthkind labs Pvt. Ltd.
  • SwisscheM Healthcare Pvt.Ltd
  • Apikos Pharma
  • Kolaz biotech.
  • CStone Pharma
  • CARsgen Therapeutics
  • JW Therapeutics
  • BeiGene
  • Takeda Pharmaceuticals
  • Astellas Pharma Inc
  • Otsuka Pharmaceutical Co.
  • Daiichi Pharmaceutical
  • Sankyo
  • China National Pharmaceutical Group Co., Ltd. (Sinopharm)
  • Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • AQVIDA GmbH
  • Baxter International Inc. (UK)
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Pfizer
  • Mylan
  • Zentiva
  • Boehringer Ingelheim
  • Merck & Co.
  • Novartis AG
  • eva Pharmaceutical Industries
  • Bristol-Myers Squibb
  • Celltrion Inc.
  • Eli Lilly and Company
  • Imugene Limited
  • Otsuka Holdings Co. Ltd
  • EMS Pharma
  • Hypermarcas
  • Eurofarma
  • Bayer
  • Teuto Brasileiro
  • Biolab Farmaceutica
  • Cristalia
  • União Quimica
  • Mantecorp Farmasa
  • Libbs
  • Cimed
  • FQM Grupo
  • Alexion Pharmaceuticals
  • Takeda
  • Spimaco
  • Hikma Pharmaceuticals
  • Jamjoom Pharma
  • Tabuk Pharmaceutical Manufacturing
  • Julphar Gulf Pharmaceuticals
  • GSK
  • Novo Nordisk
  • MSD
  • Neopharma
  • Cipla
  • Adcock Ingram
  • Eurolab
  • Ranbaxy (SA) (Pty) Ltd
  • Aspen
  • Roche

      • Table Of Contents

      1. Gastrointestinal Drugs Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.3. Segmentation By Distribution Channel

      6.4. Segmentation By Route Of Administration

      6.5. Segmentation By Drug Classification

      6.6. Segmentation By Mode Of Purchase

      7. Gastrointestinal Drugs Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Type

      7.2.1. Antacids

      7.2.2. Antiulcerants

      7.2.3. Antiemetics and Antinauseants

      7.2.4. Antidiarrheals

      7.2.5. Other

      7.3. Segmentation By Distribution Channel

      7.3.1. Hospital Pharmacies

      7.3.2. Retail Pharmacies/ Drug Stores

      7.3.3. Others

      7.4. Segmentation By Route Of Administration

      7.4.1. Oral

      7.4.2. Parenteral

      7.5. Segmentation By Drug Classification

      7.5.1. Branded Drugs

      7.5.2. Generic Drugs

      7.6. Segmentation By Mode Of Purchase

      7.6.1. Over The Counter Drugs

      7.6.2. Prescription-Based Drugs

      8. Gastrointestinal Drugs Market, Supply Chain Analysis

      8.1. Supply Chain

      8.1.1. Raw Material Suppliers

      8.1.2. Contract Research Organization (CRO)

      8.1.3. Gastrointestinal Drugs Manufacturer

      8.1.4. Contract Manufacturing Organization (CMO)

      8.2. Distribution

      8.2.1. Wholesalers/Distributors

      8.2.2. Retailers (Pharmacies) And Hospitals

      8.2.3. Gastroenterologists

      8.3. End-Users

      9. Gastrointestinal Drugs Market, Product/Service Analysis –Product Examples

      10. Gastrointestinal Drugs Market Customer Information

      10.1. COVID-19 Pandemic Effects On Gastrointestinal Diseases

      10.2. Impact Of COVID-19 On Gastrointestinal Endoscopy Units

      10.3. Americans Taking More Prescription Drugs Than Ever: Survey

      10.4. Global Prevalence Of Functional Gastrointestinal Disorders

      10.5. Prevalence Of Constipation In India

      10.6. Survey On Prescription Drugs

      10.7. Increasing Intake Of Prescription Drugs

      10.8. Irritable Bowel Syndrome A Major Gastrointestinal Disorder

      10.9. Use Of Drugs For Gastrointestinal Disorders

      10.10. Two-Thirds Of Americans Suffer From Gastrointestinal Symptoms

      11. Gastrointestinal Drugs Market Trends And Strategies

      11.1. Floating Drug Delivery System

      11.2. Use of Biomarkers for Drug Development

      11.3. Investment in Artificial Intelligence for Gastroenterology

      11.4.3D Printing Technology

      11.5. Gastro Retentive Drug Delivery Systems

      11.6. Collaboration Driving Innovation

      12. Impact Of COVID-19 On The Gastrointestinal Drugs Market

      12.1. Delays In Clinical Trials

      12.2. Supply Chain Issues

      12.3. COVID-19 Relation With Gastrointestinal Disorder

      12.4. Delay in Patient Care

      12.5. Increasing Demand for Gastrointestinal Drugs Due to COVID-19

      12.6. Future Outlook

      13. Global Gastrointestinal Drugs Market Size And Growth

      13.1. Market Size

      13.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.2.1. Drivers Of The Market 2015 – 2020

      13.2.2. Restraints On The Market 2015 – 2020

      13.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.3.1. Drivers Of The Market 2020 – 2025

      13.3.2. Restraints On The Market 2020 – 2025

      14. Gastrointestinal Drugs Market, Regional Analysis

      14.1. Global Gastrointestinal Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.2. Global Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Region

      14.3. Global Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region

      15. Global Gastrointestinal Drugs Market Segmentation

      15.1. Global Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.1.1. Antiulcerants

      15.1.2. Antacids

      15.1.3. Antiemetics And Antinauseants

      15.1.4. Antidiarrheal

      15.2. Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.3. Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.4. Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. Global Gastrointestinal Drugs Market Metrics

      16.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global

      16.2. Per Capita Average Gastrointestinal Drugs Market Expenditure, Global

      17. Asia-Pacific Gastrointestinal Drugs Market

      17.1. Asia Pacific Gastrointestinal Drugs Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. Asia-Pacific Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. Asia-Pacific Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. Asia-Pacific Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      17.6. Asia-Pacific Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      17.7. Asia-Pacific Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      17.8. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis

      17.9. Australia Gastrointestinal Drugs Market

      17.10. Australia Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.11. Australia Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.12. Australia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.13. China Gastrointestinal Drugs Market

      17.14. China Gastrointestinal Drugs Market Overview

      17.14.1. Region Information

      17.14.2. Market Information

      17.14.3. Background Information

      17.14.4. Government Initiatives

      17.14.5. Regulations

      17.14.6. Regulatory Bodies

      17.14.7. Major Associations

      17.14.8. Taxes Levied

      17.14.9. Corporate Tax Structure

      17.14.10. Investments

      17.14.11. Major Companies

      17.15. China Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.16. China Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.17. China Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.18. Hong Kong Gastrointestinal Drugs Market

      17.19. Hong Kong Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.20. Hong Kong Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.21. India Gastrointestinal Drugs Market

      17.22. India Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.23. India Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.24. India Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.25. Indonesia Gastrointestinal Drugs Market

      17.26. Indonesia Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.27. Indonesia Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.28. Indonesia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.29. Japan Gastrointestinal Drugs Market

      17.30. Japan Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.31. Japan Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.32. Japan Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.33. Malaysia Gastrointestinal Drugs Market

      17.34. Malaysia Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.35. Malaysia Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.36. New Zealand Gastrointestinal Drugs Market

      17.37. New Zealand Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.38. New Zealand Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.39. Philippines Gastrointestinal Drugs Market

      17.40. Philippines Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.41. Philippines Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.42. Singapore Gastrointestinal Drugs Market

      17.43. Singapore Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.44. Singapore Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.45. South Korea Gastrointestinal Drugs Market

      17.46. South Korea Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.47. South Korea Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.48. South Korea Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.49. Thailand Gastrointestinal Drugs Market

      17.50. Thailand Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.51. Thailand Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.52. Vietnam Gastrointestinal Drugs Market

      17.53. Vietnam Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.54. Vietnam Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18. Western Europe Gastrointestinal Drugs Market

      18.1. Western Europe Gastrointestinal Drugs Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Western Europe Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Western Europe Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Western Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Western Europe Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      18.6. Western Europe Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      18.7. Western Europe Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      18.8. Western Europe Gastrointestinal Drugs Market: Country Analysis

      18.9. Austria Gastrointestinal Drugs Market

      18.10. Austria Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.11. Austria Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.12. Belgium Gastrointestinal Drugs Market

      18.13. Belgium Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.14. Belgium Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.15. Denmark Gastrointestinal Drugs Market

      18.16. Denmark Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.17. Denmark Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.18. Finland Gastrointestinal Drugs Market

      18.19. Finland Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.20. Finland Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.21. France Gastrointestinal Drugs Market

      18.22. France Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.23. France Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.24. France Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.25. Germany Gastrointestinal Drugs Market

      18.26. Germany Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.27. Germany Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.28. Germany Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.29. Ireland Gastrointestinal Drugs Market

      18.30. Ireland Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.31. Ireland Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.32. Italy Gastrointestinal Drugs Market

      18.33. Italy Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.34. Italy Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.35. Netherlands Gastrointestinal Drugs Market

      18.36. Netherlands Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.37. Netherlands Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.38. Norway Gastrointestinal Drugs Market

      18.39. Norway Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.40. Norway Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.41. Portugal Gastrointestinal Drugs Market

      18.42. Portugal Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.43. Portugal Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.44. Spain Gastrointestinal Drugs Market

      18.45. Spain Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.46. Spain Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.47. Sweden Gastrointestinal Drugs Market

      18.48. Sweden Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.49. Sweden Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.50. Switzerland Gastrointestinal Drugs Market

      18.51. Switzerland Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.52. Switzerland Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.53. UK Gastrointestinal Drugs Market

      18.54. UK Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.55. UK Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.56. UK Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Eastern Europe Gastrointestinal Drugs Market

      19.1. Eastern Europe Gastrointestinal Drugs Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Eastern Europe Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Eastern Europe Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Eastern Europe Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      19.6. Eastern Europe Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      19.7. Eastern Europe Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      19.8. Eastern Europe Gastrointestinal Drugs Market: Country Analysis

      19.9. Czech Republic Gastrointestinal Drugs Market

      19.10. Czech Republic Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.11. Czech Republic Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.12. Poland Gastrointestinal Drugs Market

      19.13. Poland Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.14. Poland Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.15. Romania Gastrointestinal Drugs Market

      19.16. Romania Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.17. Romania Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.18. Russia Gastrointestinal Drugs Market

      19.19. Russia Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.20. Russia Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.21. Russia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. North America Gastrointestinal Drugs Market

      20.1. North America Gastrointestinal Drugs Market Overview

      20.1.1. Region Information

      20.1.2. Market Information

      20.1.3. Background Information

      20.1.4. Government Initiatives

      20.1.5. Regulations

      20.1.6. Regulatory Bodies

      20.1.7. Major Associations

      20.1.8. Taxes Levied

      20.1.9. Corporate Tax Structure

      20.1.10. Investments

      20.1.11. Major Companies

      20.2. North America Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.3. North America Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.4. North America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20.5. North America Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      20.6. North America Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      20.7. North America Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      20.8. North America Gastrointestinal Drugs Market: Country Analysis

      20.9. Canada Gastrointestinal Drugs Market

      20.10. Canada Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.11. Canada Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.12. Mexico Gastrointestinal Drugs Market

      20.13. Mexico Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.14. Mexico Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.15. USA Gastrointestinal Drugs Market

      20.16. USA Gastrointestinal Drugs Market Overview

      20.16.1. Region Information

      20.16.2. Market Information

      20.16.3. Background Information

      20.16.4. Government Initiatives

      20.16.5. Regulations

      20.16.6. Regulatory Bodies

      20.16.7. Major Associations

      20.16.8. Taxes Levied

      20.16.9. Corporate Tax Structure

      20.16.10. Investments

      20.16.11. Major Companies

      20.17. USA Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.18. USA Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.19. USA Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21. South America Gastrointestinal Drugs Market

      21.1.South America Gastrointestinal Drugs Market Overview

      21.1.1. Region Information

      21.1.2. Market Information

      21.1.3. Background Information

      21.1.4. Government Initiatives

      21.1.5. Regulations

      21.1.6. Regulatory Bodies

      21.1.7. Major Associations

      21.1.8. Taxes levied

      21.1.9. Corporate Tax Structure

      21.1.10. Investments

      21.1.11. Major Companies

      21.2. South America Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.3. South America Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.4. South America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21.5. South America Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      21.6. South America Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      21.7. South America Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      21.8. South America Gastrointestinal Drugs Market: Country Analysis

      21.9. Argentina Gastrointestinal Drugs Market

      21.10. Argentina Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.11. Argentina Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.12. Brazil Gastrointestinal Drugs Market

      21.13. Brazil Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.14. Brazil Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.15. Brazil Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21.16. Chile Gastrointestinal Drugs Market

      21.17. Chile Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.18. Chile Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.19. Colombia Gastrointestinal Drugs Market

      21.20. Colombia Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.21. Colombia Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.22. Peru Gastrointestinal Drugs Market

      21.23. Peru Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.24. Peru Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.25. Venezuela Gastrointestinal Drugs Market

      21.26. Venezuela Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.27. Venezuela Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22. Middle East Gastrointestinal Drugs Market

      22.1. Middle East Gastrointestinal Drugs Market Overview

      22.1.1. Region Information

      22.1.2. Market Information

      22.1.3. Background Information

      22.1.4. Government Initiatives

      22.1.5. Regulations

      22.1.6. Regulatory Bodies

      22.1.7. Major Associations

      22.1.8. Taxes levied

      22.1.9. Corporate Tax Structure

      22.1.10. Investments

      22.1.11. Major Companies

      22.2. Middle East Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.3. Middle East Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.4. Middle East Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      22.5. Middle East Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      22.6. Middle East Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      22.7. Middle East Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      22.8. Middle East Gastrointestinal Drugs Market: Country Analysis

      22.9. Israel Gastrointestinal Drugs Market

      22.10. Israel Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.11. Israel Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.12. Saudi Arabia Gastrointestinal Drugs Market

      22.13. Saudi Arabia Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.14. Saudi Arabia Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.15. Turkey Gastrointestinal Drugs Market

      22.16. Turkey Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.17. Turkey Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.18. UAE Gastrointestinal Drugs Market

      22.19. UAE Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.20. UAE Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23. Africa Gastrointestinal Drugs Market

      23.1. Africa Gastrointestinal Drugs Market Overview

      23.1.1. Region Information

      23.1.2. Market Information

      23.1.3. Background Information

      23.1.4. Government Initiatives

      23.1.5. Regulations

      23.1.6. Regulatory Bodies

      23.1.7. Major Associations

      23.1.8. Taxes Levied

      23.1.9. Corporate Tax Structure

      23.1.10. Investments

      23.1.11. Major Companies

      23.2. Africa Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.3.Africa Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.4. Africa Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      23.5. Africa Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)

      23.6. Africa Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      23.7. Africa Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      23.8. Africa Gastrointestinal Drugs Market: Country Analysis

      23.9. Egypt Gastrointestinal Drugs Market

      23.10. Egypt Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.11. Egypt Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.12. Nigeria Gastrointestinal Drugs Market

      23.13. Nigeria Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.14. Nigeria Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.15. South Africa Gastrointestinal Drugs Market

      23.16. South Africa Gastrointestinal Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.17. South Africa Gastrointestinal Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      24. Global Gastrointestinal Drugs Market Competitive Landscape

      24.1. Company Profiles

      24.2. Takeda Pharmaceutical Company

      24.2.1. Company Overview

      24.2.2. Products And Services

      24.2.3. Business Strategy

      24.2.4. Financial Overview

      24.3. AbbVie

      24.3.1. Company Overview

      24.3.2. Products And Services

      24.3.3. Business Strategy

      24.3.4. Financial Overview

      24.4. Johnson & Johnson

      24.4.1. Company Overview

      24.4.2. Products And Services

      24.4.3. Business Strategy

      24.4.4. Financial Overview

      24.5. Bausch Health

      24.5.1. Company Overview

      24.5.2. Products And Services

      24.5.3. Business Strategy

      24.5.4. Financial Overview

      24.6. AstraZeneca Plc

      24.6.1. Company Overview

      24.6.2. Products And Services

      24.6.3. Business Strategy

      24.6.4. Financial Overview

      25. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

      25.1. ADQ Acquired Acino

      25.2. KKR Acquired J.B. Chemicals & Pharmaceuticals Ltd

      25.3. AbbVie Acquired Allergan

      25.4. Takeda Acquired PvP Biologics

      25.5. Innovate Biopharmaceuticals, Inc. Merged With RDD Pharma, Ltd.

      25.6. Allergan Acquired Motus Therapeutics

      25.7.Valeant Acquired Salix

      26. Market Background: Pharmaceutical Drugs Market

      26.1. Pharmaceutical Drugs Market Characteristics

      26.1.1. Market Definition

      26.1.2. Segmentation By Type

      26.1.3. Central Nervous System Drugs

      26.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)

      26.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

      26.4. Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast, By Region

      27. Global Gastrointestinal Drugs Market Opportunities And Strategies

      27.1. Global Gastrointestinal Drugs Market In 2025 – Countries Offering Most New Opportunities

      27.2. Global Gastrointestinal Drugs Market In 2025 – Segments Offering Most New Opportunities

      27.3. Global Gastrointestinal Drugs Market In 2025 – Growth Strategies

      27.3.1. Market Trend Based Strategies

      27.3.2. Competitor Strategies

      28. Global Gastrointestinal Drugs Market, Conclusions And Recommendations

      28.1. Conclusions

      28.2. Recommendations

      28.2.1. Product

      28.2.2. Place

      28.2.3. Price

      28.2.4. Promotion

      28.2.5. People

      29. Appendix

      29.1. Market Data Sources

      29.2. NAICS Definitions Of Industry Covered In This Report

      29.3. Research Methodology

      29.4. Currencies

      29.5. Research Inquiries

      29.6. The Business Research Company

      29.7. Copyright And Disclaimer

    List Of Tables

      Table 1 : Global Gastrointestinal Drugs Market, Product Analysis – Product Examples
    • Table 2: Global Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 3: Global Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 4: Global Gastrointestinal Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 5: Global Gastrointestinal Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 6: Global Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 7: Global Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Table 8: Global Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 9: Global Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 10: Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 11: Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 12: Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 13: Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 14: Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 15: Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 16: Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 17: Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 18: Global Gastrointestinal Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
    • Table 19: Global Gastrointestinal Drugs Market, Per Capita Average Gastrointestinal Drugs Market Industry Expenditure, 2015 – 2025, ($)
    • Table 20:  Asia Pacific Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 21: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 22:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 23: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 24: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 25: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 26: Asia-Pacific Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 27: Asia-Pacific Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 28: Asia-Pacific Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 29: Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 30: Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 31: Asia-Pacific Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 32: Asia-Pacific Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 33: Asia-Pacific Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 34: Australia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 35: Australia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 36: Australia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 37: Australia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 38:  China Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 39:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 40: China, Population By Age Group, 2015-2025, Thousands
    • Table 41: China GDP Per Capita, 2015-2020, $
    • Table 42: China, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 43: China Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 44: China Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 45: China Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 46: China Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 47: China Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 48: Hong Kong Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 49: Hong Kong Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 50: India Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 51: India Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 52: India Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 53: India Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 54: Indonesia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 55: Indonesia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 56: Indonesia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 57: Indonesia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 58: Japan Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 59: Japan Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 60: Japan Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 61: Japan Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 62: Malaysia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 63: Malaysia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 64: New Zealand Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 65: New Zealand Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 66: Philippines Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 67: Philippines Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 68: Singapore Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 69: Singapore Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 70: South Korea Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 71: South Korea Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 72: South Korea Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 73: South Korea Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 74: Thailand Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 75: Thailand Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 76: Vietnam Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 77: Vietnam Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 78:  Western Europe Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 79:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 80:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 81: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 82: Western Europe GDP Per Capita, 2015-2020, $
    • Table 83: Western Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 84: Western Europe Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 85: Western Europe Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 86: Western Europe Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 87: Western Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 88: Western Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 89: Western Europe Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 90: Western Europe Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 91: Western Europe Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 92: Austria Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 93: Austria Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 94: Belgium Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 95: Belgium Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 96: Denmark Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 97: Denmark Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 98: Finland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 99: Finland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 100: France Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 101: France Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: France Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: France Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: Germany Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 105: Germany Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 106: Germany Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 107: Germany Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 108: Ireland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 109: Ireland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 110: Italy Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 111: Italy Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 112: Netherlands Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 113: Netherlands Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 114: Norway Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 115: Norway Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 116: Portugal Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 117: Portugal Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 118: Spain Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 119: Spain Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 120: Sweden Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 121: Sweden Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 122: Switzerland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 123: Switzerland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 124: UK Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 125: UK Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 126: UK Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 127: UK Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 128:  Eastern Europe Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 129:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 130:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 131: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 132: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 133: Eastern Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 134: Eastern Europe Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 135: Eastern Europe Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 136: Eastern Europe Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 137: Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 138: Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 139: Eastern Europe Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 140: Eastern Europe Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 141: Eastern Europe Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 142: Czech Republic Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 143: Czech Republic Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 144: Poland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 145: Poland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 146: Romania Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 147: Romania Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 148: Russia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 149: Russia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 150: Russia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 151: Russia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 152:  North America Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 153:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 154:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 155: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 156: North America GDP Per Capita, 2015-2020, $
    • Table 157: North America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 158: North America Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 159: North America Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 160: North America Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 161: North America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 162: North America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 163: North America Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 164: North America Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 165: North America Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 166: Canada Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 167: Canada Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 168: Mexico Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 169: Mexico Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 170: USA Gastrointestinal Drugs Market, Digestive Diseases, 2015-2019, Thousands
    • Table 171:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 172: USA, Population By Age Group, 2015-2025, Thousands
    • Table 173: USA GDP Per Capita, 2015-2020, $
    • Table 174: USA Home, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 175: USA Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 176: USA Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 177: USA Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 178: USA Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 179: USA Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 180: South America Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 181:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 182:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 183: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 184: South America GDP Per Capita, 2015-2020, $
    • Table 185: South America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 186: South America Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 187: South America Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 188: South America Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 189: South America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 190: South America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 191: South America Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 192: South America Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 193: South America Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 194: Argentina Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 195: Argentina Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 196: Brazil Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 197: Brazil Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 198: Brazil Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 199: Brazil Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 200: Chile Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 201: Chile Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 202: Colombia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 203: Colombia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 204: Peru Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 205: Peru Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 206: Venezuela Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 207: Venezuela Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 208:  Middle East Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 209:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 210:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 211: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 212: Middle East GDP Per Capita, 2015-2020, $
    • Table 213: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 214: Middle East Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 215: Middle East Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 216: Middle East Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 217: Middle East Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 218: Middle East Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 219: Middle East Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 220: Middle East Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 221: Middle East Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 222: Israel Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 223: Israel Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 224: Saudi Arabia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 225: Saudi Arabia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 226: Turkey Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 227: Turkey Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 228: UAE Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 229: UAE Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 230:  Africa Gastrointestinal Drugs Market, Digestive Diseases Prevalence, 2015-2019, Thousands
    • Table 231:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 232:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 233: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 234: Africa GDP Per Capita, 2015-2020, $
    • Table 235: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 236: Africa Gastrointestinal drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 237: Africa Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 238: Africa Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 239: Africa Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 240: Africa Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 241: Africa Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Table 242: Africa Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 243: Africa Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 244: Egypt Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 245: Egypt Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 246: Nigeria Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 247: Nigeria Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 248: South Africa Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 249: South Africa Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 250: Global Gastrointestinal Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 251: Takeda Pharmaceutical Company – Financial Overview, 2016 - 2020, $ Billion
    • Table 252: AbbVie – Financial Overview, 2016 - 2020, $ Billion
    • Table 253: Johnson & Johnson – Financial Overview, 2016 – 2020, $ Billion
    • Table 254: Bausch Health – Financial Overview, 2016 - 2020, $ Billion
    • Table 255: AstraZeneca Plc – Financial Overview, 2016 - 2020, $ Billion
    • Table 256: Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Table 257: Global Pharmaceutical Drugs Market, 2020, Split By Region
    • Table 258: Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 259: Global Gastrointestinal Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 260: Global Gastrointestinal Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 261: Global Gastrointestinal Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
    • Table 262: Global Gastrointestinal Drugs Market Size Gain ($ Million), Segmentation By Route Of Administration, 2020 – 2025
    • Table 263: Global Gastrointestinal Drugs Market Size Gain ($ Million), Segmentation By Drug Classification, 2020 – 2025
    • Table 264: Global Gastrointestinal Drugs Market Size Gain ($ Million), Segmentation By Mode Of Purchase, 2020 – 2025
    • Table 265: Gastrointestinal Drugs - Market Data Sources

    List Of Figures

      Figure 1: Global Gastrointestinal Drugs Market Segmentation By Type
    • Figure 2: Global Gastrointestinal Drugs Market Segmentation By Distribution Channel
    • Figure 3: Global Gastrointestinal Drugs Market Segmentation By Route Of Administration
    • Figure 4: Global Gastrointestinal Drugs Market Segmentation By Drug Classification
    • Figure 5: Global Gastrointestinal Drugs Market Segmentation By Mode Of Purchase
    • Figure 6: Market Supply Chain For Gastrointestinal Drugs
    • Figure 7: Global Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 8: Global Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 9: Global Gastrointestinal Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Figure 11: Global Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Figure 12: Global Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: Asia-Pacific Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 18: Asia-Pacific Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Asia-Pacific Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 21: Asia-Pacific Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 22: Asia-Pacific Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 23: Australia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Australia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Australia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: China Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 27: China Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 28: China Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Hong Kong Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 30: Hong Kong Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: India Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 32: India Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: India Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 35: Indonesia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: Indonesia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: Japan Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 38: Japan Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: Japan Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: Malaysia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 41: Malaysia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: New Zealand Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 43: New Zealand Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: Philippines Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 45: Philippines Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 46: Singapore Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Singapore Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: South Korea Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 49: South Korea Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: South Korea Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Thailand Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Thailand Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Vietnam Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 54: Vietnam Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 55: Western Europe Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Western Europe Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Western Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Western Europe Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 59: Western Europe Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 60: Western Europe Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 61: Austria Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 62: Austria Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: Belgium Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 64: Belgium Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: Denmark Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 66: Denmark Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 67: Finland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 68: Finland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: France Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 70: France Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: France Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: Germany Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 73: Germany Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 74: Germany Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Ireland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Ireland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Italy Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 78: Italy Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 79: Netherlands Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Netherlands Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Norway Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 82: Norway Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Portugal Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Portugal Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Spain Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 86: Spain Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 87: Sweden Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 88: Sweden Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 89: Switzerland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 90: Switzerland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 91: UK Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 92: UK Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 93: UK Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 94: Eastern Europe Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 95: Eastern Europe Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 96: Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 97: Eastern Europe Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 98: Eastern Europe Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 99: Eastern Europe Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 100: Czech Republic Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 101: Czech Republic Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 102: Poland Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 103: Poland Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 104: Romania Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 105: Romania Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 106: Russia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 107: Russia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 108: Russia Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 109: North America Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 110: North America Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 111: North America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 112: North America Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 113: North America Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 114: North America Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 115: Canada Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 116: Canada Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 117: Mexico Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 118: Mexico Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 119: USA Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 120: USA Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 121: USA Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 122: South America Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 123: South America Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 124: South America Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 125: South America Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 126: South America Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 127: South America Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 128: Argentina Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 129: Argentina Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 130: Brazil Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 131: Brazil Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 132: Brazil Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 133: Chile Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 134: Chile Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 135: Colombia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 136: Colombia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 137: Peru Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 138: Peru Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 139: Venezuela Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 140: Venezuela Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 141: Middle East Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 142: Middle East Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 143: Middle East Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 144: Middle East Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 145: Middle East Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 146: Middle East Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 147: Israel Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 148: Israel Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 149: Saudi Arabia Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 150: Saudi Arabia Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 151: Turkey Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 152: Turkey Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 153: UAE Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 154: UAE Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 155: Africa Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 156: Africa Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 157: Africa Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 158: Africa Gastrointestinal Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 159: Africa Gastrointestinal Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 160: Africa Gastrointestinal Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 161: Egypt Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 162: Egypt Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 163: Nigeria Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 164: Nigeria Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 165: South Africa Gastrointestinal Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 166: South Africa Gastrointestinal Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 167: Global Gastrointestinal Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 168: Takeda Pharmaceutical Company – Financial Overview, 2016 – 2020, $ Billion
    • Figure 169: AbbVie – Financial Overview, 2016 – 2020, $ Billion
    • Figure 170: Johnson & Johnson –  Financial Overview, 2016 – 2020,$ Billion
    • Figure 171: Bausch Health – Financial Overview, 2016 – 2020, $ Billion
    • Figure 172: AstraZeneca Plc – Financial Overview, 2016 – 2020, $ Billion
    • Figure 173: Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Figure 174: Global Pharmaceutical Drugs Market, 2020, Split By Region
    • Figure 175: Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Compression Therapy Market Overview In 2022?

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

    View Report